Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (23593)	7/27/1998 8:38:00 PM
From: bob zagorin	Read Replies (1) \| Respond to of 32384

hate to disturb the barnyard animals (tony,fugazi,mudcat..i wonder who chose their handles and yes, it is curious that they don't use their real names while most others here do) but. today was a nice reversal off a bottom for LGND. TC2000 "moneystream also turned up while BOP remains in yellow positive.

To: Henry Niman who wrote (23593)	7/27/1998 9:01:00 PM
From: Machaon	Read Replies (1) \| Respond to of 32384

<< he will pick an arguement with just about anyone who has anything positive to say about LGND. >> Most understand that this is abnormal behaviour. Once in a while, you can expect a disagreement, but week after week after week. Does anyone know the word obsession? A minority of posters probably have psychological profiles similar to tonyt. I've had to deal with many, many people. I've grown to expect aberrant behaviour, but by the minority. Just like there are physical differences and defects, there are also mental differences and defects. I've done a lot of study, and had hundreds of conversations, about this very same subject. But the bottom line is: Ligand's science will go on for many years after the memory of tonyt's annoying remarks fade into the trashbin of the meaningless. On Topic: Ligand does not have a partner for Panretin or Targretin, right? Do they owe Allergan any royalties from these products? Ligand has 16+ products, for which they don't have a partner. It sounds to me that they intend to go both ways, as a development company, and as a drug company. Regards, Bob